Susquehanna International Group, LLP Heron Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.73 - $3.67 $3,287 - $6,973	1,900 Added 4.96%	40,200 $79,000
Q2 2024 Aug 15, 2024	SELL	$2.32 - $3.86 $186,528 - $310,344	-80,400 Reduced 67.73%	38,300 $134,000
Q1 2024 May 07, 2024	SELL	$1.71 - $3.06 $26,505 - $47,430	-15,500 Reduced 11.55%	118,700 $328,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $72,468 - $244,244	134,200 New	134,200 $228,000
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $31,725 - $65,847	-14,100 Reduced 43.52%	18,300 $45,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $37,772 - $76,254	14,200 Added 78.02%	32,400 $137,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $192,969 - $527,731	-83,900 Reduced 82.17%	18,200 $51,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $399,106 - $856,828	86,200 Added 542.14%	102,100 $584,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $1.5 Million - $2.22 Million	-148,000 Reduced 90.3%	15,900 $170,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $1.97 Million - $2.82 Million	136,300 Added 493.84%	163,900 $2.66 Million
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $496,155 - $1.19 Million	-48,500 Reduced 63.73%	27,600 $324,000
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $181,168 - $276,744	10,400 Added 15.83%	76,100 $1.79 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $782,008 - $1.02 Million	-47,800 Reduced 42.11%	65,700 $1.22 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $9.26 Million - $14.3 Million	-547,100 Reduced 82.82%	113,500 $2.11 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $12.9 Million - $15.8 Million	558,100 Added 544.49%	660,600 $16.1 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $524,314 - $761,838	23,800 Added 30.24%	102,500 $2.66 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $3.89 Million - $5.3 Million	-129,800 Reduced 62.25%	78,700 $2.49 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $5.15 Million - $8.2 Million	-195,200 Reduced 48.35%	208,500 $8.1 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $5.22 Million - $8.15 Million	283,000 Added 234.47%	403,700 $11.1 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $868,760 - $1.11 Million	58,700 Added 94.68%	120,700 $2.19 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $908,300 - $1.04 Million	62,000	62,000 $1 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$29.9 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.91 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.77 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$9.32 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.83 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account